✦ LIBER ✦

Prospective Evaluation of Imaging Procedures for the Detection of Pancreaticoduodenal Endocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1

✍ Scribed by Peter Langer; Peter H. Kann; Volker Fendrich; Gerd Richter; Saskia Diehl; Matthias Rothmund; Detlef K. Bartsch

Publisher: Springer
Year: 2004
Tongue: English
Weight: 147 KB
Volume: 28
Category: Article
ISSN: 0364-2313
DOI: 10.1007/s00268-004-7642-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of multiple endocrine neoplas

Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours

✍ P. Langer; A. Wild; A. Hall; I. Celik; M. Rothmund; D. K. Bartsch 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

Mutation analysis of the MEN1 gene in Be

Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases

✍ Jacques Poncin; Roger Abs; Brigitte Velkeniers; Maryse Bonduelle; Marc Abramowic 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 2 views

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by tumors in parathyroids, enteropancreatic endocrine tissues, anterior pituitary, and other tissues. The gene for MEN1 has recently been cloned and shown to code for a 610-amino acid protein of enigmatic func

Malignant melanoma in patients with mult

Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma

✍ Brita Nord; Anton Platz; Kristina Smoczynski; Soili Kytölä; Gavin Robertson; Ala 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 98 KB 👁 1 views

Lack of allelic loss at the multiple end

Lack of allelic loss at the multiple endocrine neoplasia type 1(MEN-1) gene locus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with the MEN-1 syndrome

✍ Cesare Bordi; Cinzia Azzoni; Tiziana D'Adda; Anacleto Peracchia; Alberto Falchet 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 951 KB

The gene responsible for multiple endocrine neoplasia type I (MEN-l) syndrome has been mapped to chromosome l lq13. It appears to function as a tumoursuppressor gene analogous to that for retinoblastoma and allelic losses involving the wild-type of the MEN-1 allele have been found in parathyroid and

Octreotide improves biochemical, radiolo

Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN-1) : Implications for an integrated model of MEN-1 tumorigenesis

✍ John R. Burgess; Tim M. Greenaway; Venkateswaran Parameswaran; Joseph J. Shepher 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Multiple endocrine neoplasia type 1 (MEN-1) is an autosomal dominant tumor syndrome associated with parathyroid, gastroenteropancreatic (GEP), and pituitary neoplasia. Gastrinoma and GEP malignancy are common life-threatening endocrine complications of MEN-1. An effective management strategy for the

A metastatic neuroendocrine anaplastic s

A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging with 111in-pentetreotide

✍ Kenneth J. O'Byrne; Michael G. Goggins; Dermot P. Kelleher; Donald G. Weir; Geor 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

Extrapulmonary small cell and small cell neuroendocrine tumors of unknown primary site are, in general, aggressive neoplasms with a short median survival. Like small cell lung cancer (SCLC), they often are responsive to chemotherapy and radiotherapy. Small cell lung cancer and well differentiated ne